via Reddit
Algorithm that performs as accurately as dermatologists
A study has now been presented that boosts the evidence for using AI solutions in skin cancer diagnostics. With an algorithm they devised themselves, scientists at the University of Gothenburg show the capacity of technology to perform at the same level as dermatologists in assessing the severity of skin melanoma.
The study, published in the Journal of the American Academy of Dermatology, and its results are the work of a research group at the Department of Dermatology and Venereology at Sahlgrenska Academy, University of Gothenburg.
The study was conducted at Sahlgrenska University Hospital in Gothenburg. Its purpose was, through machine learning (ML), to train an algorithm to determine whether skin melanoma is invasive and there is a risk of it spreading (metastatizing), or whether it remains at a growth stage in which it is confined to the epidermis, with no risk of metastasis.
The algorithm was trained and validated on 937 dermatoscopic images of melanoma, and subsequently tested on 200 cases. All the cases included were diagnosed by a dermatopathologist.
Algorithm vs dermatologist
The majority of melanomas are found by patients rather than doctors. This suggests that, in most cases, diagnosis is relatively easy. Before surgery, however, it is often much more difficult to determine the stage the melanoma has reached.
To make the classifications more accurate, dermatologists use dermatoscopes — instruments that combine a type of magnifying glass with bright illumination. In recent years, interest in using ML for skin tumor classifications has increased, and several publications have shown that ML algorithms can perform on par with, or even better than, experienced dermatologists.
The current study is now giving a further boost to research in this field. When the same classification task was performed by the algorithm on the one hand and seven independent dermatologists on the other, the result was a draw.
Support for patients and doctors
“None of the dermatologists significantly outperformed the ML algorithm,” states Sam Polesie, a researcher at the University of Gothenburg and specialist doctor at Sahlgrenska University Hospital, who is the corresponding author of the study.
In a developed form, the algorithm could serve as support in the task of assessing the severity of skin melanoma before surgery. The classification affects how extensive an operation needs to be, and is therefore important for both the patient and the surgeon.
“The results of the study are interesting, and the hope is that the algorithm can be used as clinical decision support in the future. But it needs refining further, and prospective studies that monitor patients over time are necessary, too,” Polesie concludes.
Original Article: Algorithm that performs as accurately as dermatologists
More from: University of Gothenburg
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Skin cancer diagnostics
- NovaScan inks distribution deal for skin cancer detection device
Chicago-based oncology detection tech firm NovaScan gears up to launch a device it says will improve the way surgeons tackle cancerous skin lesions.
- Epredia, NovaScan to ink distribution agreement for MarginScan to aid doctors to detect non-melanoma skin cancer
Portsmouth, New Hampshire Saturday, May 4, 2024, 15:00 Hrs [IST] ...
- NovaScan selects Epredia to distribute MarginScan device in US
Skin cancer is the most diagnosed cancer globally ... Epredia president Steven Lynum said: “With more than 85 years supporting precision cancer diagnostics, we strive to continuously serve the ...
- Epredia and NovaScan Announce Intent to Enter U.S. Distribution Agreement for MarginScan™ Device for Non-Melanoma Skin Cancer Detection
Skin cancer is the most common group of cancers diagnosed ... MarginScan™ will be the latest addition to Epredia’s world-class portfolio of precision cancer diagnostics products and services that ...
- How AI-Driven Diagnostics Can Save Lives When Humans Can’t
AI offers promise in improving diagnostics, detecting conditions faster and more accurately than humans. It can alleviate staff workload and improve health outcomes ...
Go deeper with Google Headlines on:
Skin cancer diagnostics
[google_news title=”” keyword=”skin cancer diagnostics” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Artificial intelligence diagnostics
- Progressive Role of Artificial Intelligence in Treatment Decision - Making in the Field of Medical Oncology
Artificial intelligence (AI) has started to play an important role in oncologic medicine today, focusing mainly on oncologic diagnosis (by helping in cancer radiology & pathology) and radiation ...
- Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
Quest Diagnostics DGX recently announced a strategic collaboration with PathAI, a global leader in artificial intelligence-powered pathology technology, aimed at revolutionizing cancer and disease ...
- Quest plans to purchase PathAI’s diagnostic lab as part of AI ramp-up
AI and digital technologies have tremendous potential to improve cancer care, and Quest has the know-how to scale and deliver innovations that are high quality, efficient and broadly accessible," said ...
- Artificial Intelligence in Diagnostics Market CAGR of 32.3%, Size Poised for Takeoff in the Coming Years
Artificial Intelligence in Diagnostics Market is valued approximately at USD 288 million in 2019 and is anticipated to grow with a healthy growth rate of more than 32.3% over the forecast period ...
- Artificial intelligence expands diagnostic horizons in coronary angiography
New insights from the AI-ENCODE study showed artificial intelligence (AI) successfully allowed the ... Coronary angiography is a widely used diagnostic procedure for identifying coronary artery ...
Go deeper with Google Headlines on:
Artificial intelligence diagnostics
[google_news title=”” keyword=”artificial intelligence diagnostics” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]